Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
778,961
-
Share change
-
-27,146
-
Total reported value
-
$5,928,000
-
Price per share
-
$7.61
-
Number of holders
-
20
-
Value change
-
-$205,949
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q4 2015
As of 31 Dec 2015,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
778,961 shares.
The largest 10 holders included
683 Capital Management, LLC, Park West Asset Management LLC, PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GRT CAPITAL PARTNERS L.L.C., MENTA CAPITAL LLC, GOLDMAN SACHS GROUP INC, and CapWealth Advisors, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.